Literature DB >> 28608161

The diagnostic value of high-frequency power-based diffusion-weighted imaging in prediction of neuroepithelial tumour grading.

Zhiye Chen1,2, Peng Zhou3,4, Bin Lv5, Mengqi Liu1,2, Yan Wang1, Yulin Wang1, Xin Lou1, Qiuping Gui6, Huiguang He7,8,9, Lin Ma10.   

Abstract

OBJECTIVES: To retrospectively evaluate the diagnostic value of high-frequency power (HFP) compared with the minimum apparent diffusion coefficient (MinADC) in the prediction of neuroepithelial tumour grading.
METHODS: Diffusion-weighted imaging (DWI) data were acquired on 115 patients by a 3.0-T MRI system, which included b0 images and b1000 images over the whole brain in each patient. The HFP values and MinADC values were calculated by an in-house script written on the MATLAB platform.
RESULTS: There was a significant difference among each group excluding grade I (G1) vs. grade II (G2) (P = 0.309) for HFP and among each group for MinADC. ROC analysis showed a higher discriminative accuracy between low-grade glioma (LGG) and high-grade glioma (HGG) for HFP with area under the curve (AUC) value 1 compared with that for MinADC with AUC 0.83 ± 0.04 and also demonstrated a higher discriminative ability among the G1-grade IV (G4) group for HFP compared with that for MinADC except G1 vs. G2.
CONCLUSIONS: HFP could provide a simple and effective optimal tool for the prediction of neuroepithelial tumour grading based on diffusion-weighted images in routine clinical practice. KEY POINTS: • HFP shows positive correlation with neuroepithelial tumour grading. • HFP presents a good diagnostic efficacy for LGG and HGG. • HFP is helpful in the selection of brain tumour boundary.

Entities:  

Keywords:  Diffusion-weighted imaging; High-frequency power; Magnetic resonance imaging; Minimum apparent diffusion coefficient; Neuroepithelial tumour grading

Mesh:

Year:  2017        PMID: 28608161     DOI: 10.1007/s00330-017-4899-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

Review 1.  Receiver operating characteristic analysis: a tool for the quantitative evaluation of observer performance and imaging systems.

Authors:  Charles E Metz
Journal:  J Am Coll Radiol       Date:  2006-06       Impact factor: 5.532

2.  Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.

Authors:  S H Torp
Journal:  Clin Neuropathol       Date:  2002 Nov-Dec       Impact factor: 1.368

3.  Grade classification of neuroepithelial tumors using high-resolution magic-angle spinning proton nuclear magnetic resonance spectroscopy and pattern recognition.

Authors:  WenXue Chen; HaiYan Lou; HongPing Zhang; Xiu Nie; WenXian Lan; YongXia Yang; Yun Xiang; JianPin Qi; Hao Lei; HuiRu Tang; FenEr Chen; Feng Deng
Journal:  Sci China Life Sci       Date:  2011-07-12       Impact factor: 6.038

4.  Grading glial tumors with amide proton transfer MR imaging: different analytical approaches.

Authors:  Akihiko Sakata; Tomohisa Okada; Akira Yamamoto; Mitsunori Kanagaki; Yasutaka Fushimi; Tsutomu Okada; Toshiki Dodo; Yoshiki Arakawa; Benjamin Schmitt; Susumu Miyamoto; Kaori Togashi
Journal:  J Neurooncol       Date:  2015-01-06       Impact factor: 4.130

5.  Diagnostic value of minimum apparent diffusion coefficient values in prediction of neuroepithelial tumor grading.

Authors:  Zhiye Chen; Lin Ma; Xin Lou; Zhenhong Zhou
Journal:  J Magn Reson Imaging       Date:  2010-06       Impact factor: 4.813

6.  Imaging regional variation of cellular proliferation in gliomas using 3'-deoxy-3'-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study.

Authors:  S J Price; T D Fryer; M C Cleij; A F Dean; J Joseph; R Salvador; D D Wang; P J Hutchinson; J C Clark; N G Burnet; J D Pickard; F I Aigbirhio; J H Gillard
Journal:  Clin Radiol       Date:  2008-09-04       Impact factor: 2.350

7.  Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data.

Authors:  Sebastian Herminghaus; Thomas Dierks; Ulrich Pilatus; Walter Möller-Hartmann; Jörg Wittsack; Gerhard Marquardt; Christoph Labisch; Heinrich Lanfermann; Wolfgang Schlote; Friedhelm E Zanella
Journal:  J Neurosurg       Date:  2003-01       Impact factor: 5.115

8.  Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET.

Authors:  Tatsuro Tsuchida; Hiroaki Takeuchi; Hidehiko Okazawa; Tetsuya Tsujikawa; Yasuhisa Fujibayashi
Journal:  Nucl Med Biol       Date:  2008-02       Impact factor: 2.408

Review 9.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

10.  Quantitative Analysis of Diffusion Weighted MR Images of Brain Tumor Using Signal Intensity Gradient Technique.

Authors:  S S Shanbhag; G R Udupi; K M Patil; K Ranganath
Journal:  J Med Eng       Date:  2014-05-28
View more
  3 in total

1.  Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.

Authors:  Xiao-Wei Kang; Yi-Bin Xi; Ting-Ting Liu; Ning Wang; Yuan-Qiang Zhu; Xing-Rui Wang; Fan Guo
Journal:  BMC Med Imaging       Date:  2020-05-14       Impact factor: 1.930

2.  Diagnostic Implications of White Matter Tract Involvement by Intra-axial Brain Tumors.

Authors:  Saqib Kamran Bakhshi; Ayesha Quddusi; Shaikh D Mahmood; Muhammad Waqas; Muhammad Shahzad Shamim; Fatima Mubarak; Syed Ather Enam
Journal:  Cureus       Date:  2021-11-08

3.  Predictive Role of the Apparent Diffusion Coefficient and MRI Morphologic Features on IDH Status in Patients With Diffuse Glioma: A Retrospective Cross-Sectional Study.

Authors:  Jun Zhang; Hong Peng; Yu-Lin Wang; Hua-Feng Xiao; Yuan-Yuan Cui; Xiang-Bing Bian; De-Kang Zhang; Lin Ma
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.